Trials / Withdrawn
WithdrawnNCT02697162
Antiseptic-coated Intermittent Urinary Catheter
Antiseptic-coated Intermittent Urinary Catheter: Efficacy and Feasibility of Neurogenic Bladder Management and Prevention of Catheter-associated Urinary Tract Infections in Children
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Children's Hospital Zagreb · Academic / Other
- Sex
- All
- Age
- 1 Month – 18 Years
- Healthy volunteers
- Not accepted
Summary
Study design is a prospective, randomised, double-blind, and interventional. Primary aim of the study is to investigate efficacy of antiseptic-coated intermittent hydrophilic urinary catheters in prevention and reduction of catheter-associated urinary tract infections in children with neurogenic bladder. Secondary aim is to assess feasibility of antiseptic-coated intermittent hydrophilic urinary catheters in neurogenic bladder management. Octenidine chloride will be used as antiseptic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Antiseptic-coated catheter | Antiseptic-coated hydrophilic intermittent urinary catheter with octenidine chloride |
| DEVICE | Hydrophilic catheter | Hydrophilic intermittent urinary catheter |
| DRUG | Octenidine chloride | Antiseptic |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-12-01
- Completion
- 2018-06-01
- First posted
- 2016-03-03
- Last updated
- 2021-02-09
Locations
1 site across 1 country: Croatia
Source: ClinicalTrials.gov record NCT02697162. Inclusion in this directory is not an endorsement.